Pages that link to "Q30400584"

The following pages link to Vaccinate for the next H2N2 pandemic now. (Q30400584):

Displaying 42 items.

• Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies (Q26823492) (← links)
• Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity (Q27673861) (← links)
• A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin (Q27676298) (← links)
• Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets (Q27697913) (← links)
• International society for disease surveillance conference 2011: building the future of public health surveillance (Q28732714) (← links)
• Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus (Q30205252) (← links)
• Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates (Q30206089) (← links)
• Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic (Q30223015) (← links)
• Risk assessment of H2N2 influenza viruses from the avian reservoir (Q30355580) (← links)
• Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets. (Q30357270) (← links)
• Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus. (Q30365079) (← links)
• One-health approach as counter-measure against "autoimmune" responses in biosecurity. (Q30369133) (← links)
• Emerging influenza viruses and the prospect of a universal influenza virus vaccine. (Q30372274) (← links)
• Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression (Q30372625) (← links)
• H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers. (Q30373298) (← links)
• Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses. (Q30377531) (← links)
• Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. (Q30379886) (← links)
• Evaluation of multivalent H2 influenza pandemic vaccines in mice (Q30398507) (← links)
• A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains. (Q30402334) (← links)
• Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza (Q30406880) (← links)
• Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses (Q30414712) (← links)
• Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design (Q30416502) (← links)
• Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011 (Q30417814) (← links)
• Comprehensive global amino acid sequence analysis of PB1F2 protein of influenza A H5N1 viruses and the influenza A virus subtypes responsible for the 20th-century pandemics (Q30419097) (← links)
• Vaccination against influenza: role and limitations in pandemic intervention plans (Q30421562) (← links)
• Characterization of a novel reassortant influenza A virus (H2N2) from a domestic duck in Eastern China (Q34760846) (← links)
• Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities (Q36276614) (← links)
• Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south (Q36467169) (← links)
• Host versus flu: antibodies win a round? (Q37146938) (← links)
• Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses (Q38287871) (← links)
• Tackling influenza with broadly neutralizing antibodies (Q39319893) (← links)
• Genetic characterization of an H2N2 influenza virus isolated from a muskrat in Western Siberia (Q40130168) (← links)
• Genetic and molecular characterization of a novel reassortant H2N8 subtype avian influenza virus isolated from a domestic duck in Zhejiang Province in China. (Q40476799) (← links)
• Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice (Q41921267) (← links)
• Public health: Life lessons (Q41978537) (← links)
• Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010. (Q42176260) (← links)
• Vaccines for the twenty-first century society (Q51664205) (← links)
• Influenza A(H5N1) vaccines: are we better prepared for the next pandemic? (Q51861188) (← links)
• Population Serologic Immunity to human and avian H2N2 viruses in the United States and Hong Kong for Pandemic Risk Assessment. (Q54211362) (← links)
• New approaches to vaccination (Q57170110) (← links)
• Editorial: which influenza subtype should be added to the next vaccine? (Q84459829) (← links)
• Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay (Q91592191) (← links)